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Introduction: Sarcoidosis is recognized as a multiorgan disorder characterized by the presence of non-caseating
granulomas in the involved tissues. It has been suggested that sarcoidosis might be due to the exposure to
infectious or non-infectious agents in genetically susceptible individuals. In particular, Propionibacterium acnes and
Mycobacterium tuberculosis have been considered causative microorganisms. We report a case of P. acnes-associated
sarcoidosis in which a drastic improvement was achieved with clarithromycin administration. A possible mechanism
of clarithromycin action is discussed.
Case presentation: A 78-year-old Japanese-Mongoloid woman with P. acnes-associated sarcoidosis presented with
a persisting fever, joint pains and generalized lymph node swelling. The diagnosis of sarcoidosis was confirmed by
pathological and immunohistochemical studies of a biopsied lymph node. In this case, an oral administration of
clarithromycin was applied. Soon after the initiation of this treatment her symptoms as well as lymph node swelling
disappeared. The clarithromycin treatment was discontinued 3.5 months after its initiation. She is currently in good
condition. The pathological analysis of her lymph node, which was obtained during the clarithromycin treatment,
suggested an apoptosis-inducing effect of clarithromycin on the sarcoid granulomas.
Conclusions: Clarithromycin was found to be effective for treating sarcoidosis and seems to have important
pharmacological effects such as immunosuppression, immunomodulation and induction of apoptosis in addition to
its antimicrobial role. In this case, apoptosis in the sarcoid granulomas induced by clarithromycin administration
might have resulted in satisfactory improvement.
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TreatmentIntroduction
Sarcoidosis is recognized as a multiorgan disorder charac-
terized by the presence of non-caseating granulomas in
the involved tissues [1]. The disease involves predomin-
antly the skin, eyes, lungs and lymph nodes, especially the
hilar lymph nodes. Many studies of sarcoidosis have sug-
gested that it might be due to the exposure to infectious or
non-infectious agents in genetically susceptible individzuals
[1,2]. In particular, Propionibacterium acnes (P. acnes) and
Mycobacterium tuberculosis have been studied extensively
as causative microorganisms. Latent infection of P. acnes* Correspondence: takemori_nobuo@circus.ocn.ne.jp
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reproduction in any medium, provided the orhas been emphasized as a cause of sarcoidosis [3], since
P. acnes is the only microorganism that has been iso-
lated from sarcoid lesions by bacterial culture [4].
Clarithromycin (CAM), a member of the macrolide
family, is a widely used antimicrobial drug. It is also
known to have other important pharmacological effects
such as immunosuppression or immunomodulation [5,6].
We report here a rare case of sarcoidosis in which a dras-
tic improvement was achieved with CAM administration.
A possible mechanism of CAM action including its anti-
microbial, immunosuppressive, immunomodulatory and
apoptosis-inducing effects in the treatment of sarcoidosis
is discussed.al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A 78-year-old Japanese-Mongoloid woman (body weight:
48kg) with a 3-year history of hypertension and hyperlip-
idemia visited our hospital because of a persisting fever
and generalized joint pains which had developed 2 weeks
before initial presentation. She had been treated as having
a common cold at a local clinic for 2 weeks previously,
but her symptoms had not improved. After visiting our
hospital, a drip infusion therapy of cefpirome with oral
administration of loxoprofen was initiated on an out-
patient basis. However, this treatment was not effective
for the fever but caused toxic eruptions on the back of
both her hands. Thus, this treatment was suspended
3 days later. She was admitted 4 days after initial pres-
entation. Neither respiratory nor ocular symptoms were
present. She had past history of panhysterectomy due to
uterine cancer at the age of 38 and a fracture of her left
wrist joint at the age of 68. She had no environmental
or occupational history of beryllium or other metal ex-
posure. A physical examination on admission showed
bilateral inguinal and axillary lymph node swelling and
erythematous eruptions on the back of both her hands.
A chest X-ray showed minimal bilateral hilar lymphaden-
opathy (BHL); however, a chest computed tomography
(CT) scan clearly revealed mild BHL without pulmonary
infiltrates (Figure 1). Since respiratory function tests were
normal, bronchoscopy was not performed. Electrocar-
diogram and ophthalmologic evaluations were normal.
A complete blood cell count showed slight anemia (red
blood cell count, 3.70×1012/L; hemoglobin, 10.8g/dL),
slight leukocytosis (white blood cell count, 11.9×109/L
with 74% neutrophils, 13% lymphocytes, 11% monocytes,
1% eosinophils, and 1% basophils) and normal platelet
count (360×109/L). Elevated levels of erythrocyte sedi-
mentation rate (110mm/hour), C-reactive protein (CRP;
13.73mg/dL; normal range 0 to 0.26mg/dL), soluble-A
B
Figure 1 Chest X-ray and computed tomography scan images on admi
with clear lung fields. (B) Chest computed tomography scan clearly showing
infiltrates.interleukin (IL)-2 receptors (s-IL2R; 1300IU/mL; normal
range 124 to 466IU/mL), antinuclear antibodies (×640;
normal range <×40) and ferritin (722ng/mL; normal range
39.4 to 340ng/mL), and reduced levels of serum iron
(34μg/dL; normal range 54 to 181μg/dL) and albumin
(2.5g/dL; normal range 3.9 to 4.9g/dL) were observed.
Serum electrolytes and renal function indices were nor-
mal. Rheumatoid arthritis particle agglutination, anti-
double-stranded deoxyribonucleic acid (DNA), anti-Sm,
anti-thyroglobulin, anti-microsome, anti-Ro and anti-La
antibody titers were within normal limits. No incre-
ments of serum angiotensin-converting enzyme and
lysozyme were seen. The results of an anti-acid fast bac-
terium antibody and a tuberculin skin test were negative
(0×0mm). Serologic tests for syphilis, hepatitis B virus,
hepatitis C virus and human immunodeficiency virus
were negative. Serum Epstein–Barr virus (EBV) and
Chlamydia pneumoniae titers showed prior infection
patterns. The results of serologic studies for Cytomegalo-
virus, Brucella, Legionella, Coxiella burnetii, Mycoplasma
and Toxoplasma were negative. Her urine showed nothing
remarkable.
A positron emission tomography-CT (PET-CT) scan,
which was carried out 4 days after admission, showed
18F-fluorodeoxyglucose (FDG) uptakes in her peripharyn-
geal, axillary, mediastinal, hilar, iliac and inguinal lymph
nodes with splenic involvement. In addition, remarkable
FDG uptake at her submandibular dental roots wearing
ceramic crowns was observed, suggesting chronic peri-
odontitis (Figure 2).
A right inguinal lymph node biopsy specimen, which
was obtained 9 days after the initiation of CAM treatment,
showed non-caseating epithelioid cell granulomas with
abundant multinucleated giant cells (Langhans giant cells)
in the background of epithelioid cells, macrophages, lym-
phocytes and plasma cells (Figure 3A). In the present case,ssion. (A) Chest X-ray showing minimal bilateral hilar lymphadenopathy
mild bilateral hilar lymphadenopathy (arrows) without pulmonary
Figure 2 Positron emission tomography-computed tomography images on admission. (A) Coronal and sagittal positron emission tomography
images on admission showing 18F-fluorodeoxyglucose uptake in peripharyngeal, axillary, mediastinal, hilar, iliac and inguinal lymph nodes and spleen.
An arrow indicates 18F-fluorodeoxyglucose uptake at submandibular dental roots, suggesting submandibular periodontitis. (B) Fused positron emission
tomography-computed tomography image showing left hilar lymph node swelling with moderate 18F-fluorodeoxyglucose uptake. (C) Fused positron
emission tomography-computed tomography image showing remarkable 18F-fluorodeoxyglucose uptake in the spleen.
A B
Figure 3 Histopathology of the lymph node. (A) Langhans giant cells with various degrees of eosin stainability are seen. One giant cell (black
arrow) shows moderately eosinophilic condensed cytoplasm, and another one (blue arrow) has a remarkably eosinophilic condensed cytoplasm
with multiple condensed nuclei. Hematoxylin and eosin stain (under×20 magnification objective). (B) The sarcoid granuloma consisting of
epithelioid cells is somewhat ill defined from surrounding tissue. Lymphocytes are seen surrounding the sarcoid granuloma, which is reminiscent
of cellular immune reaction. Hematoxylin and eosin stain (under×40 magnification objective).
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size and number, and ill defined from surrounding tissue
(Figure 3B). In addition, some of the giant cells showed
condensed heterochromatin (pyknosis; Figure 3A), mul-
tiple fragmented nuclei (apoptotic bodies; Figure 4A)
and multiple nuclear remnants with indistinct nuclear
configurations in the eosinophilic condensed cytoplasm
(Figure 4B). These findings indicate that the giant cells
were, although atypical, in the apoptotic process accord-
ing to the features described by Wyllie et al. [7]. These
degenerated giant cells appeared to have transformed into
eosinophilic homogenous substances with fibrotic config-
uration (that is, hyaline-like degeneration; Figure 4C). The
degenerating/degenerated giant cells showed slightly in-
creased stainability with periodic acid–Schiff (Figure 4D).
Neither acid-fast bacterium nor fungus was demonstrated
by Ziehl–Neelsen and Grocott stains (not shown). Immu-
nohistochemical staining for Mycobacterium tuberculosis
showed a negative result (not shown). EBV-encoded small
ribonucleic acid (RNA) was not detected in the sarcoid
granulomas (not shown). To demonstrate the presence of
P. acnes in the granulomas, the lymph node specimens
were tested by immunohistochemistry using a specific
monoclonal antibody against P. acnes lipoteichoic acid
(PAB antibody). PAB-positive reaction products wereA
C
Figure 4 Histopathology of the lymph node. (A) Multiple fragmented
degenerated giant cell (arrow) with fibrotic configuration. Hematoxylin an
eosinophilic degenerated giant cells (blue and black arrows) showing ind
stage of degeneration. One cell (blue arrow) shows fibrotic configuration.
eosin stain (under×20 magnification objective). (C) Black arrows indicate t
degeneration) with fibrotic configuration. Nuclear remnants are barely vis
cells to hyaline-like degeneration is shown. Hematoxylin and eosin stain (
(black arrow) and a degenerated giant cell (blue arrow) showing increased
magnification objective).observed preferentially in the degenerated homogenous
substances. Small positive dots were scattered sparsely in
the sarcoid granulomas (Figure 5).
Since a considerable number of plasma cells were
admixed with lymphocytes in the lymph node, immuno-
histochemical staining was carried out for immunoglobu-
lin (Ig) G, IgA, IgM, IgD and IgG4 to dispel the possibility
of IgG4-related disease (Figure 6). Infiltrated plasma cells
were positive for IgG, IgA, IgM, IgD and IgG4 at different
degrees. Positive reactions for IgG4 were only occasionally
seen in the plasma cells, thus negating the possibility of
IgG4-related disease. Some of the giant cells and degen-
erated homogenous substances were positively stained
with anti-IgG antibody, and the reaction was more
intense in degenerating/degenerated giant cells than in
intact ones (Figure 6A). The giant cells were faintly
stained with anti-IgD antibody (Figure 6B) but not with
anti-IgA (not shown), anti-IgM (not shown) and anti-IgG4
(Figure 6C) antibodies.
In this case, an oral administration of CAM (200mg at
12-hour intervals) coupled with acetaminophen (400mg
at 12-hour intervals) was empirically initiated on the
day of admission. After the initiation of this treatment,
her fever rapidly subsided coupled with the disappear-
ance of joint pains and toxic eruptions within 1 week.B
D
condensed nuclei (apoptotic bodies) are seen in the eosinophilic
d eosin stain (under×40 magnification objective). (B) Two
istinct nuclear configurations, which are probably in the advanced
Yellow arrows indicate relatively intact giant cells. Hematoxylin and
hree eosinophilic homogenous degenerated substances (hyaline-like
ible. Morphological transition from degenerating/degenerated giant
under×20 magnification objective). (D) A degenerating giant cell





Figure 5 Propionibacterium acnes within sarcoid granulomas in the lymph node. Hematoxylin and eosin staining (left) and immunostaining with
PAB antibody specific to Propionibacterium acnes (counterstained with hematoxylin) (right) are shown pairwise. (A, B) Square indicates an eosinophilic
homogenous degenerated substance (hyaline-like degeneration). Positive reaction products (brown dots) are located preferentially in the
hyaline-like degeneration (under×40 magnification objective). (C, D) In the sarcoid granuloma, a small positive dot is seen in an epithelioid cell
(red arrow). Some fine reaction products are sparsely scattered in the sarcoid granuloma. A black arrow indicates a Langhans giant cell
(under×40 magnification objective). Abbreviations: HE, hematoxylin and eosin; P., Propionibacterium.
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2 weeks and elevated s-IL2R levels were remarkably de-
creased within 3 weeks (Figure 7). She was discharged
25 days after admission and followed as an out-patient.
Administration of acetaminophen was suspended at
the time of discharge. The levels of s-IL2R returned to
normal within 2 months. The follow-up PET-CT scan
2 months after admission showed minimal FDG uptake
in her bilateral hilar lymph nodes and distinct uptake
at submandibular dental roots and in peripharyngeal
lymph nodes. The FDG uptake in her spleen also dis-
appeared (Figure 8). CAM treatment was discontinued
3.5 months after its initiation. No unfavorable adverse
effects were observed with CAM. During the course of
illness, the patient was found to have urinary bladder
cancer, which was successfully removed by endoscopy
in the urologic department of another hospital. Her
levels of s-IL2R remained slightly elevated (less than
750IU/mL) after cessation of CAM treatment without
any symptoms. She stopped visiting our hospital
1.5 years after initial presentation because of traffic in-
convenience to visit the hospital. Recently, she visited
our hospital to undergo medical check-ups and was
told that she was in good condition.Discussion
Although the exact cause of sarcoidosis is still unknown,
the current working hypothesis suggests that it is caused
by alteration of the immune response after exposure to
environmental, occupational or infectious agents in
genetically susceptible individuals. Among the infectious
agents, mycobacterial and propionibacterial organisms are
most commonly implicated as potential etiologic agents
[1-4,8-10]. In particular, P. acnes is the only microorgan-
ism that has been isolated from sarcoid lesions [4]. Many
fragments of P. acnes nucleic acids have been detected in
sarcoid lymph nodes by quantitative polymerase chain re-
action [11-13] and in situ hybridization [13]. All available
evidence has suggested the concept that the disease results
from an exaggerated Th1 immune response to specific
antigens [1,2,8,14]. Moller et al. suggested that IL-12
induction and amplification of Th1 responses probably
play an important role in the granuloma development
in sarcoidosis through the effect of interferon-γ (IFN-γ)
on macrophage activation [15]. The fact that the sarcoid
granulomas can be experimentally induced in mice by
administration of a recombinant trigger-factor protein
of P. acnes lends supportive evidence for hypersensitivity
to P. acnes [16].
CAM 400mg/day
CRP: 13.6  8.6            3.2    1.2     0.9             0.23       0.1 (mg/dL)
s-IL2R: 1300                                      478 (U/mL)







Lymph node biopsy (9 days after admission)
39
Figure 7 Clinical course during admission. After the initiation of clarithromycin treatment, the fever subsided within 1 week. The elevated
levels of C-reactive protein returned to normal within 2 weeks and elevated soluble-interleukin-2 receptor levels were remarkably depressed






Figure 6 Immunohistochemical staining of the lymph node for immunoglobulin G, immunoglobulin D and immunoglobulin G4.
(A) Degenerating giant cells (yellow arrows) and degenerated homogenous substance, possible hyaline-like degeneration (black arrows), are
moderately positive for immunoglobulin G. By contrast, an intact giant cell (white arrow) is negative for immunoglobulin G. Infiltrated plasma cells
are distinctly positive for immunoglobulin G (under×20 magnification objective). (B) The giant cell (arrow) is faintly positive for immunoglobulin
D (under×20 magnification objective). (C) The giant cells are negative for immunoglobulin G4. The immunoglobulin G4-positive plasma cells are
sporadic in frequency (under×20 magnification objective). Abbreviations: IgD, immunoglobulin D; IgG, immunoglobulin G; IgG4,
immunoglobulin G4.
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Figure 8 Positron emission tomography and fused positron emission tomography-computed tomography images 2 months after admission.
Drastic resolution in axillary, mediastinal, iliac and inguinal lymph nodes is shown. The spleen (yellow arrow) shows no 18F-fluorodeoxyglucose uptake.
However, submandibular dental roots (blue arrow) and peripharyngeal lymph nodes (black arrow) still show 18F-fluorodeoxyglucose uptake.
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tochemically using PAB antibody. Positive reaction prod-
ucts were found preferentially in eosinophilic degenerated
homogenous substances. The presence of P. acnes in
the lymph node seems to be the supportive evidence for
diagnosing sarcoidosis. Furthermore, its presence in the
lymph node indicates that the sarcoidosis was caused by
P. acnes infection. The pathology of the lymph node in
this case was key to understanding the degenerative
process of Langhans giant cells. Some of the degenerating/
degenerated giant cells showed apoptotic features. In
addition, morphological transition from degenerated
giant cells to hyaline-like substances was also observed.
Thus, many giant cells were seen to undergo apoptosis
due to the CAM treatment. Taking into account the
apoptosis in the giant cells, it is possible that epithelioid
cells might also have been involved in apoptosis. However,
it was difficult to identify apoptotic features in individual
epithelioid cells in the granulomas at the light microscopic
level. The presence of IgG and IgD in the giant cells might
be related to the apoptotic process because IgG was
stained more intensely in the degenerating/degenerated
giant cells as well as in the hyaline-like substances than
in the intact giant cells. The presence of IgG and IgD in
the giant cells might be due to incorporation of Igs by
endocytosis or increased permeability of the cell mem-
brane. In this connection, the incorporation of M-protein
(IgG), possibly by endocytosis, has been demonstrated by
immunoelectron microscopy in various bone marrow cells
such as erythroblasts, monocytes, reticulum cells, mega-
karyocytes, and stromal cells in a case of IgG-κ typemultiple myeloma [17]. Thus, it is not surprising that the
IgG and IgD were detected immunohistochemically in the
giant cells. Non-specific reaction for IgG and IgD seems
improbable because no positivity for IgG4, IgA, and IgM
was demonstrated in the giant cells by the same immuno-
histochemical procedure. The exact mechanism and the
significance of incorporated Igs remain to be elucidated,
but this may reflect the degree of degeneration of the giant
cells.
In the present case, typical clinical features for sarcoid-
osis such as pulmonary, ocular or cutaneous lesions were
not observed. Moreover, her levels of serum angiotensin-
converting enzyme and lysozyme were not elevated. How-
ever, the PET-CT scan clearly showed axillary, mediastinal,
hilar, iliac and inguinal lymph node swellings with massive
splenic involvement. The diagnosis of sarcoidosis was
made histopathologically based on the presence of non-
caseating epithelioid granulomas with abundant Langhans
giant cells in her lymph node. Although histologic evi-
dence is mandatory for a definitive diagnosis of sarcoid-
osis, the histologic findings are not sufficiently specific to
make the diagnosis, since non-caseating granulomas are
found in a number of infectious diseases. In the present
case, such a possibility was ruled out by negative serologic
tests for Brucella, Legionella, Coxiella burnetii, Myco-
plasma and Toxoplasma species. Serologic tests for
EBV and Chlamydia pneumoniae showed prior infection
patterns. In addition, EBV-encoded small RNA was nega-
tive in the sarcoid granulomas. Legionella infection was
unlikely because the patient had no pneumonia at presen-
tation. Leishmaniasis is also unlikely because this disease
Takemori et al. Journal of Medical Case Reports 2014, 8:15 Page 8 of 9
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not observed in the biopsied lymph node. Although P.
acnes seems to be a potential etiologic agent, other viral,
bacterial and environmental agents and genetic suscep-
tibility might be also involved in the development of
sarcoidosis in a complex manner.
In general, sarcoidosis can either remit spontaneously or
become chronic, with exacerbation and remission. Two-
thirds of the patients with sarcoidosis generally have a
remission within a decade after diagnosis with few or no
consequences. Remission occurs in more than half of
the patients within 3 years [2]. In most cases, patients
with sarcoidosis are not disabled by the illness, so the
decision and selection of its treatment should be provided
with discretion. A variety of drugs including corticosteroids,
methotrexate (MTX), azathioprine, thalidomide, cyclophos-
phamide, cyclosporine, hydroxychloroquine, chloroquine,
nonsteroidal anti-inflammatory drugs and anti-tumor ne-
crosis factor (TNF)-α blockers have been tried [2]. Bachelez
et al. [18] reported that in 12 patients with cutaneous
sarcoidosis treated with minocycline, a clinical response
was observed in 10 patients, which consisted of complete
responses in eight patients and partial response in two
patients. The use of minocycline and its analogues have
also been proposed because of their antimicrobial and
immunomodulatory effects [18]. Recently, it was reported
that minocycline treatment for sarcoidosis reduced the cir-
culating levels of IL-12p40 and interferon (IFN)-inducible
protein-10, thus emphasizing the immunomodulating
rather than antimicrobial effects of the drug [19]. In the
present case, we started CAM treatment without a def-
inite diagnosis of sarcoidosis at the time of admission.
The diagnosis of sarcoidosis was only confirmed patho-
logically 2 weeks after the initiation of CAM treatment.
Soon after the initiation of this treatment, CAM was
found to be effective; the fever rapidly subsided with de-
pressed levels of CRP and s-IL2R. Baba et al. [20] reported
a case of sarcoidosis with multiple endobronchial mass
lesions which disappeared after treatment with CAM
coupled with minocycline. However, there has been no
report documenting a drastic effect for sarcoidosis after
a single CAM administration. Although acetaminophen
might have played a role in depressing the fever to a cer-
tain extent, the drug itself has no immunomodulatory or
immunosuppressive effect. Thus, CAM was thought to
have played a major role in improving sarcoidosis.
Recently, we reported a case of MTX-related EBV-
associated Hodgkin-like lymphoma, in which complete re-
mission was achieved after withdrawal of MTX coupled
with CAM administration [21]. We emphasized that
CAM has important pharmacological effects such as
immunosuppression or immunomodulation in addition
to an antimicrobial role. It is postulated that CAM can
influence the cytokine networks and enhance the activitiesof natural killer cells and cytotoxic T-cells [22]. Many
investigators have reported immunosuppressive or immu-
nomodulatory effects of CAM in patients with cancers
[23,24] or tumor-bearing animals [22]. In brief, CAM can
decrease the production of IL-1 [5,21,25], IL-2 [6,26,27],
IL-5 [26], IL-6 [5,6,21,24,26,27], IL-8 [6,28], TNF-α
[5,21,24,26,29], transforming growth factor-β [29] and
matrix metalloproteinase 9 [29], and increase the pro-
duction of IL-4 [22], IL-12 [23] and IFN-γ [22,23]. In
the present case, the level of cytokines was not investi-
gated. However, the pathology of the biopsied lymph
node was very suggestive to understand the mode of
action by CAM; the sarcoid granulomas clearly showed
apoptotic degeneration in Langhans giant cells. In this
connection, CAM has been reported to induce apop-
tosis of activated human lymphocytes [30]. Here, atten-
tion should be paid to the fact that the lymph node
biopsy was carried out 9 days after the initiation of
CAM treatment. This means that CAM had already
exerted its pharmacological effect on the sarcoid granu-
lomas at the time of biopsy. In other words, pathological
findings of the lymph node represented the healing
process by CAM treatment.
In the present case, the PET-CT images consistently
showed distinct FDG uptake at the submandibular dental
roots, suggesting the presence of chronic periodontitis.
Concomitant FDG uptake in peripharyngeal lymph nodes
seemed to be related with chronic periodontitis. P. acnes
is known to be indigenous to the skin, it is also considered
to be important in the etiology of periodontal diseases. In
this case, the possibility that the chronic periodontitis
might have been a focus of P. acnes infection cannot be
ruled out.
Conclusions
The present case provided helpful clues in the treatment
of P. acnes-associated sarcoidosis. CAM was found to be
effective for treating sarcoidosis, and seems to have im-
portant pharmacological effects such as immunosuppres-
sion, immunomodulation and induction of apoptosis in
addition to its antimicrobial role. The pathological analysis
of the lymph node, which was obtained during the CAM
treatment, demonstrated an apoptosis-inducing effect of
CAM on the sarcoid granulomas. This effect might have
resulted in satisfactory improvement in this case.
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